Unlike some of the OHAs that lead to weight gain and hypoglycaemia, GLP-1 analogues have been shown to produce weight loss in type 2 diabetes, and have a lower risk of causing hypoglycaemia [39]–[41]. Here, GCG is linked to Hypoglycemia.